Livagen
Khavinson liver bioregulator
Livagen is a Khavinson tetrapeptide bioregulator (Lys-Glu-Asp-Ala / KEDA) originally isolated from liver tissue extracts in Russian gerontology research. It has been studied in animal and cell-culture models for hepatocyte function, chromatin decondensation in lymphocytes, and liver-related ageing parameters, alongside other organ-targeted Khavinson peptides such as Pancragen and Cortagen. Sold by research-peptide vendors at 5–20 mg vial sizes for laboratory work; not approved by FDA, MHRA, Health Canada, or TGA for human use. Research-use only — Pepticker does not provide medical advice and this entry summarises published preclinical research, not a dosing protocol.
Also known as: KEDA, Liver bioregulator
Cost-per-dose recalculates as you adjust the calculator above.
Research use only. The compounds listed on this page are not approved for human use through research-chemical channels. Nothing on this page is medical advice. Consult a qualified clinician before considering any peptide protocol. See affiliate disclosure and our scoring methodology.